Bumper Offer - Urjas oil Just @ Rs. 1
Gabawin 25 Tablet is a prescription drug, available for use as Tablet. It is primarily used for the treatment of Neuropathic Pain, Epilepsy, Anxiety. The alternative uses of Gabawin 25 Tablet have also been explained below.
The right dosage of Gabawin 25 Tablet depends on the age, gender, and medical history of the patient. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. This information has been provided in detail in the dosage section.
Some other side effects of Gabawin 25 Tablet have been listed ahead. Normally, these side effects of Gabawin 25 Tablet are not long lasting and go away when the treatment is finished. Please speak with your doctor if these side effects worsen or persist for a longer duration.
In addition, Gabawin 25 Tablet's effect is Moderate during pregnancy and Severe for lactating mothers. It is important to know if Gabawin 25 Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Gabawin 25 Tablet related warnings section.
Some other conditions that can be affected by Gabawin 25 Tablet are listed in the contraindications section below.
Besides this, Gabawin 25 Tablet may also have severe interaction with some medicines. Refer to the list below for further details.
You should also be aware that Gabawin 25 Tablet is not safe while driving, and is not addiction.
Gabawin 25 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Gabawin 25 Tablet is used -
Moderate
Mild
Is the use of Gabawin 25 Tablet safe for pregnant women?
Pregnant women may experience moderate side effects from Gabawin. It is best to stop taking Gabawin immediately and inform your doctor if you notice any discomfort.
Is the use of Gabawin 25 Tablet safe during breastfeeding?
Gabawin should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.
What is the effect of Gabawin 25 Tablet on the Kidneys?
Gabawin may have mild side effects on the kidneys.
What is the effect of Gabawin 25 Tablet on the Liver?
Gabawin does not damage the liver.
What is the effect of Gabawin 25 Tablet on the Heart?
Gabawin is not harmful for the heart.
Gabawin 25 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Gabawin 25 Tablet unless your doctor advises you to do so -
Is this Gabawin 25 Tablet habit forming or addictive?
Gabawin 25 Tablet does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Gabawin 25 Tablet as you may feel sleepy.
Is it safe?
Yes, but consume Gabawin 25 Tablet only on doctor's advice.
Is it able to treat mental disorders?
Yes, this Gabawin 25 Tablet works for mental disorders.
Interaction between Food and Gabawin 25 Tablet
Taking Gabawin 25 Tablet with food is safe.
Interaction between Alcohol and Gabawin 25 Tablet
Taking alcohol with Gabawin 25 Tablet can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lyrica (pregabalin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1048-1049
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lyrica (pregabalin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1048-1049
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lyrica (pregabalin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1048-1049
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lyrica (pregabalin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1048-1049
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lyrica (pregabalin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1048-1049
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420